
Hefti-LF Tablet
Marketer
Zuno Pharmaceuticals
Salt Composition
Artemether (80mg) + Lumefantrine (480mg)
Overview Hefti-LF Tablet
Malarone-equivalent tablets treat malaria in adults and children. This dual-action medication comprises two antimalarial drugs. It's effective against malaria parasites, halting infection spread, but isn't for malaria prevention or severe cases involving organ complications (brain, lungs, kidneys). For optimal absorption, take with food, following your doctor's prescribed dosage and duration. Exceeding the recommended dose is unsafe. Complete the entire course for effective treatment. Common side effects include headache, appetite loss, fatigue, and muscle or joint pain; dizziness may also occur. Report persistent or worsening symptoms to your physician. Disclose all current medications to your doctor before use. Pregnant or lactating individuals should only use this medication under strict medical supervision due to potential fetal harm.
Uses of Hefti-LF Tablet
Managing Malaria Infection
Major Benefits of Hefti-LF Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Hefti-LF Tablets should be administered with a meal.
Common Side effects of Hefti-LF Tablet:
- Headache
- Loss of appetite
- Dizziness
- Weakness
- Joint pain
- Muscle pain
How to use Hefti-LF Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Hefti-LF Tablet with a meal.
How Hefti-LF Tablet works:
Artemether and lumefantrine, the active components of Hefti-LF Tablets, offer a dual-action approach to malaria treatment. By elevating blood heme concentrations, a substance harmful to the malaria parasite, this combination effectively eliminates the parasite and halts disease progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Hefti-LF Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Hefti-LF Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Hefti-LF Tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Hefti-LF Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
Exercise caution when administering Hefti-LF Tablets to individuals with severe renal impairment; dosage modification might be necessary. Physician consultation is advised. Severe kidney disease does not necessitate dosage alteration.
LiverCAUTION
Patients with severe hepatic impairment should use Hefti-LF Tablets cautiously. Dosage modification for Hefti-LF Tablets may be necessary; physician consultation is advised. Severe hepatic impairment does not necessitate dosage alteration.
What if you forget to take Hefti-LF Tablet :
Should you forget a Hefti-LF Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Hefti-LF Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimalarial Medications |
